Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial
- 1 June 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9117) , 1677-1681
- https://doi.org/10.1016/s0140-6736(97)08169-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987)European Journal Of Cancer, 1997
- Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancerThe Lancet, 1995
- Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burdenInternational Journal of Cancer, 1993
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I)Cancer, 1990
- Adjuvant Therapy of Colorectal CancerPublished by American Medical Association (AMA) ,1988
- A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancerBritish Journal of Surgery, 1985
- Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectumDiseases of the Colon & Rectum, 1982
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958